Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-184798
Filing Date
2005-09-13
Accepted
2005-09-13 16:54:48
Documents
8
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 785260
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 4498
3 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2136
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 6255
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 6258
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4003
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4249
8 GRAPHIC g98163img.jpg GRAPHIC 67828
  Complete submission text file 0001193125-05-184798.txt   908000
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338377
VIRAGEN INTERNATIONAL INC (Filer) CIK: 0000785081 (see all company filings)

EIN.: 112788282 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-17827 | Film No.: 051082679
SIC: 2836 Biological Products, (No Diagnostic Substances)